Jun Wu

Jun Wu

Auto-generated profile, based on publicly available information

Jun Wu

Department of Oncology, The Third Affiliated Hospital of Soochow University, Changzhou, China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2014 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
XLXiaodong Li
Xiaodong Li
MJMei Ji
Mei Ji
XZXiao Zheng
Xiao Zheng
ZNZhong-Hua Ning
Zhong-Hua Ning
JWJun Wu
Jun Wu
JJJingting Jiang
Jingting Jiang
CIK cells therapy has been evaluated as an adoptive cell immunotherapy for cancer patients, but there still have not been any standardized systems for evaluating the antitumor efficacy yet. The WHO and RECIST criteria have already been established for a few years but not sufficient to fully characterize the activity of immunotherapy. Based on these two criteria, the irRC was proposed for evaluating the efficacy of immunotherapy. A variety of bioassays for immune monitoring including the specific and non-specific methods, have been established. We recommend detect levels of various immunocytes, immune molecules and soluble molecules to find the correlations among them and clinicopathological characteristics to establish criteria for immunological classification. We also recommend a paradigm shift for the oncologists in the evaluation of immune therapies to ensure assessment of activity based on clinically relevant criteria and time points.

28 May 2014 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
WZWei-Qing Zhao
Wei-Qing Zhao
XLXiaodong Li
Xiaodong Li
HSHongbing Shi
Hongbing Shi
JWJun Wu
Jun Wu
JZJiaming Zhang
Jiaming Zhang
CWChang-Ping Wu
Chang-Ping Wu
We aimed to detect CD40 mutant expression and evaluate its clinical significance in gastric cancer.